Clinically proven to even out skin tone by 15.07%, reduce dark spots by 8.04% and increase skin brightness by 2.63% in 4 weeks. Skin irritation tests completed, making it safe to use for sensitive and acne-prone skin types
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
However, people with certain medical conditions or those receiving B12 injections may experience negative side effects or overdose symptoms
Piperine was known for the enhancement of bioavailability of the drug components from the ancient times
These symptoms mainly relate to the digestive, metabolic and nervous system
These symptoms can significantly reduce a persons quality of life and, if not treated, can cause life-threatening complications
